Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors (Q40388768)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors
scientific article

    Statements

    Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors (English)
    Taroh Satoh
    Isamu Okamoto
    Masaki Miyazaki
    Ryotaroh Morinaga
    Asuka Tsuya
    Yoshikazu Hasegawa
    Masaaki Terashima
    Shinya Ueda
    Masahiro Fukuoka
    Yutaka Ariyoshi
    Toshikazu Saito
    Noriyuki Masuda
    Hirokazu Watanabe
    Tetsuo Taguchi
    Toru Kakihara
    Yumiko Aoyama
    Yohko Hashimoto
    Kazuhiko Nakagawa
    26 May 2009
    3872-3880

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit